Presidio Partners

Copyright © Presidio Partners

Design by Sterling Communications

Investments in Exela Pharma Sciences to secure & support U.S based drug supply & manufacturing

...

September 23, 2021

Solaria Corporation Unveils World Class Executive Team

...

Altimmune Completes First Development Milestone Toward A Single-Dose Intranasal COVID-19 Vaccine

...

Lifesize and Serenova Merge

...

Wildcat raises more than $20M Series C financing

...

December 7, 2019

Ardelyx receives FDA approval

...

December 7, 2019

Solaria Raises $40M to Double Its Module Production Capacity

...

December 7, 2019

Altimmune Announces Closing of Acquisition of Spitfire Pharma

...

September 14, 2019

Inventure Renewables, Wilmar and Desmet Ballestra Announce Agreement to Build New Plant

Facility in Taizhou China Will Process Waste from...

Arista Acquires Mojo Networks

...

Menlo Therapeutics Inc. Announces Pricing of Initial Public Offering of Common Stock

...

February 12, 2018

Corsair Pharma and United Therapeutics Enter into Strategic Collaboration to Advance Novel Treprostinil Prodrugs

...

January 12, 2018

Solaria Raises $23 Million In Funding To Expand Manufacturing Of Its Breakthrough Solar Modules (PDF)

...

January 12, 2018

Dianrong Names Executive Chairman, Co-Chairman and CEO

...

January 12, 2018

Press Releases: Odyssey Logistics & Technology Receives Equity Investment from The Jordan Company

...

December 5, 2017

Singapore’s GIC leads $220 million funding round for Chinese P2P lender Dianrong

...

August 23, 2017

Menlo Therapeutics Raises $50M

...

Soligent to distribute Solaria PowerXT modules nationwide

...

Dianrong Acquires Asset-Origination Operations of Quark Finance – Dianrong Focus Special Report

...

A123 Systems Completes $5M Equity Investment in Wildcat Discovery Technologies

Wildcat Discovery Technologies, Inc., recently completed an $8M...

Mojo Networks: The Age of Cognitive WiFi (CIO Review)

...

Menlo Therapeutics Announces Successful Pruritus Reduction Results from Phase 2 Serlopitant Trial (TCP-102) in 127 Subjects With Prurigo Nodularis

...

Petrobras and Foro Energy Announce Signing Extension of Technology Cooperation Agreement

...

February 16, 2017

Mojo Networks Closes $30 Million to Fuel Growth and Further Disrupt the WiFi Networking Industry

...

February 8, 2017

LiveOps Appoints New CEO to Lead Contact Center BPO Business

...

January 6, 2017

Menlo Therapeutics Recruits Experienced Management Team and Board Leadership to Accelerate Development of Serlopitant for Treatment of Pruritus

...

January 5, 2017

LiveOps Cloud Becomes Serenova, Simplifies Customer Experience

...

October 18, 2016

LiveOps Appoints Chief Operating Officer

...

September 19, 2016

Untangle Announces Acquisition by Providence Equity

...

September 12, 2016

Inventure Announces Partnership With Mazzoni To Process Refinery By-product Lipid Into Value-added Oleochemicals

...

Ensemble Therapeutics Announces Global Pharma Partner Expands Access to IL-17 Assets

...

Odyssey Logistics & Technology Posts Earnings Growth of 18 Percent

...

February 9, 2016

Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT™

...

January 27, 2016

CONMED Completes Acquisition of SurgiQuest, Inc.

...

January 4, 2016

Marlin Equity Partners to Acquire LiveOps Cloud Platform Business

...

December 1, 2015

CONMED Announces Definitive Agreement to Acquire SurgiQuest, Inc.

...

November 16, 2015

FLEX TO EXPAND ITS SOLAR OFFERING BY ADDING INNOVATIVE SOLAR TRACKING SOLUTIONS THROUGH THE STRATEGIC ACQUISITION OF NEXTRACKER

...

September 8, 2015

Neos Therapeutics Announces Pricing of Initial Public Offering

...

Ardelyx Regains Worldwide Development and Commercialization Rights for Its Late-Stage Development Candidate, Tenapanor, and Related Portfolio of NHE3 Compounds

...

Baxter Ventures, Mayo Clinic and Velocity Pharmaceutical Development Announce the Formation of Vitesse Biologics, LLC, a Company Structured to Accelerate Therapeutic Innovation

...

Neos Therapeutics Announces Trade Name Cotempla XR-ODT™ for its Methylphenidate Extended-Release Orally Disintegrating Tablets

...

SurgiQuest Names Jaime Landman, M.D. Chief Medical Director

...

Neos Therapeutics, Inc. Appoints Thomas P. McDonnell As Chief Commercial Officer

...

Presidio Partners Announces New Fund, Unveils New Corporate Identity, and Announces Additional Senior Management

— Peter Gajdos Tapped as Managing Director, Lee...

Cnano Technology Limited Completes $15 Million Series C Financing

...

Neos Therapeutics Completes $20.6 Million Financing to Further Advance its Late-Stage ADHD Product Pipeline

...

February 25, 2015

Arcadia Biosciences And Mahyco Achieve Product Development Milestone For Water Use Efficient Rice

...

February 9, 2015

Wildcat Discovery Technologies DOE Vehicle Technologies Award Generates Promising Si Anode Electrolyte Leads

...

January 25, 2015

Neos Therapeutics Announces Submission of a New Drug Application for its Methylphenidate Extended Release Oral Disintegrating Tablet (XR-ODT) for the Treatment of ADHD

...

January 12, 2015

Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus

...

December 17, 2014

Neos Therapeutics Announces Issuance of Key Patent Covering its Extended Release Oral Disintegrating Tablet (XR-ODT) Platform Technology

...

October 8, 2014

ARCADIA BIOSCIENCES AND ARBORGEN TO DEVELOP DROUGHT-TOLERANT AND NITROGEN-EFFICIENT EUCALYPTUS TREES

...

October 7, 2014

Jobvite Secures $25 Million Of Expansion Capital Led By Catalyst Investors

...

October 7, 2014

Neos Therapeutics Acquires all Commercialization and Profit Rights to Generic Tussionex® (Extended Release Hydrocodone Polistirex/Chlorpheniramine Polistirex) from Chiesi USA and Coating Place, Inc.

...

September 8, 2014

Petrobras and Foro Energy Announce Signing of Technology Cooperation Agreement

...

August 26, 2014

Odyssey Logistics & Technology Corp. (Odyssey) Announces the Acquisition of ADS Logistics

...

August 16, 2014

ARCADIA BIOSCIENCES RECEIVES U.S. PATENT FOR EXTENDED SHELF LIFE TOMATOES

...

Neos Therapeutics Announces Positive Phase 3 Study Results for its Methylphenidate Extended-Release (XR) Oral Disintegrating Tablet (ODT) in ADHD Patients

...

Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Regulatory Clearance for Initiating Phase II Study with VPD-737 in Prurigo Nodularis

...

Ardelyx Announces Pricing Of Its Initial Public Offering

...

ARCADIA BIOSCIENCES LAUNCHES SONOVA® ULTRA GLA SAFFLOWER OIL

...

Neos Therapeutics, Inc. Announces the Appointment of Richard I. Eisenstadt as Chief Financial Officer

...

Ardelyx Receives $25 Million Milestone From AstraZeneca For Commencement Of Phase 2b Clinical Trial Of Tenapanor

...

ARCADIA BIOSCIENCES RAISES $33 MILLION SERIES D INVESTMENT

...

‘Adderall’ up: Neos gets $18M series C plus $20M loan deal for AD

...

Neos Therapeutics Announces $20 Million Loan Facility and Updated Total of $18 Million for its Additional Series C Financing

...

China Is Now World Leader in Graphene and Carbon Nanotube Research

...

Teva Reinforces Leadership Position in CNS with Acquisition of Auspex

...

Auspex Announces Completion Of Initial Public Offering

...

February 10, 2014